Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-04-08 Sale | 2024-04-09 6:37 pm | OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer | 6,954 | $5.27 | $36,648 | 407,183 (Direct) | View |
2021-02-04 Sale | 2021-02-05 5:03 pm | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 18,097 | $178.5 | $3,230,376 | 35,861 (Direct) | View |
2020-06-04 Sale | 2020-06-05 4:07 pm | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 11,146 | $118.59 | $1,321,775 | 40,877 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-11-01 Option Award(A) | 2024-04-23 5:42 pm | N/A N/A | OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer | 366,511 | $0 | 305,412 (Direct) | View |
2024-04-07 Exercise | 2024-04-09 6:37 pm | N/A N/A | OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer | 13,541 | $0 | 407,183 (Direct) | View |
2024-02-16 Option Award | 2024-02-20 6:22 pm | N/A N/A | OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer | 284,375 | $0 | 838,549 (Direct) | View |
2024-02-15 Tax Withholding | 2024-02-20 6:22 pm | N/A N/A | OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer | 7,609 | $5.54 | 838,549 (Direct) | View |
2024-02-15 Exercise | 2024-02-20 6:22 pm | N/A N/A | OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer | 21,322 | $0 | 838,549 (Direct) | View |
2024-01-02 Tax Withholding | 2024-01-03 5:42 pm | N/A N/A | OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer | 7,195 | $6.25 | 381,121 (Direct) | View |
2024-01-02 Exercise | 2024-01-03 5:42 pm | N/A N/A | OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer | 17,556 | $0 | 381,121 (Direct) | View |
2023-12-07 Exercise(A) | 2023-12-12 6:26 pm | N/A N/A | OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer | 15,622 | $0 | 126,360 (Direct) | View |
2023-12-07 Tax Withholding | 2023-12-11 7:21 pm | N/A N/A | OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer | 5,403 | $4.85 | 715,100 (Direct) | View |
2023-12-07 Exercise | 2023-12-11 7:21 pm | N/A N/A | OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer | 15,622 | $0 | 715,100 (Direct) | View |
2023-04-07 Option Award | 2023-04-11 7:11 pm | N/A 2033-04-07 | OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer | 284,375 | $0 | 658,314 (Direct) | View |
2023-02-15 Tax Withholding | 2023-02-17 7:50 pm | N/A N/A | OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer | 9,543 | $3.8 | 373,939 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 5:06 pm | N/A N/A | OmniAb Inc. | OABI | Berkman Charles S See Remarks | 46,864 | $0 | 383,482 (Direct) | View |
2022-12-28 Tax Withholding | 2022-12-30 5:00 pm | N/A N/A | OmniAb Inc. | OABI | Berkman Charles S See Remarks | 6,518 | $3.66 | 336,618 (Direct) | View |
2022-12-07 Option Award | 2022-12-09 6:00 pm | N/A 2032-12-07 | OmniAb Inc. | OABI | Berkman Charles S See Remarks | 175,477 | $0 | 175,477 (Direct) | View |
2022-12-01 Tax Withholding | 2022-12-05 9:41 pm | N/A N/A | OmniAb Inc. | OABI | Berkman Charles S See Remarks | 10,580 | $3.35 | 343,136 (Direct) | View |
2022-11-01 Option Award | 2022-11-03 9:16 pm | N/A 2025-02-10 | OmniAb Inc. | OABI | Berkman Charles S See Remarks | 790,522 | $0 | 790,522 (Direct) | View |
2022-11-01 Option Award | 2022-11-03 9:08 pm | N/A 2032-05-05 | OmniAb Operations Inc. | Berkman Charles S CLO & Secretary | 51,219 | $0 | 35,810 (Direct) | View | |
2022-11-01 Disposition | 2022-11-03 9:08 pm | N/A 2032-05-05 | OmniAb Operations Inc. | Berkman Charles S CLO & Secretary | 141,724 | $0 | 35,810 (Direct) | View | |
2022-11-01 Disposition | 2022-11-03 9:06 pm | N/A 2032-05-05 | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S Former Executive Officer | 32,070 | $0 | 23,825 (Direct) | View |
2022-06-10 Option Award | 2022-06-14 5:55 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 5,375 | $0 | 35,769 (Direct) | View |
2022-05-05 Option Award | 2022-05-09 8:10 pm | N/A 2032-05-05 | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 20,126 | $0 | 20,126 (Direct) | View |
2022-02-15 Tax Withholding | 2022-02-16 8:24 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 1,578 | $123.68 | 30,394 (Direct) | View |
2022-01-26 Option Award | 2022-01-28 8:42 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 6,237 | $0 | 31,972 (Direct) | View |
2022-01-26 Tax Withholding | 2022-01-28 8:42 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 2,156 | $113.68 | 31,972 (Direct) | View |
2021-02-15 Tax Withholding | 2021-02-18 6:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 1,015 | $172.46 | 27,891 (Direct) | View |
2021-02-03 Option Award | 2021-02-05 5:03 pm | N/A 2021-02-03 | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 10,446 | $0 | 35,861 (Direct) | View |
2021-01-25 Option Award | 2021-01-27 7:02 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 3,736 | $0 | 43,512 (Direct) | View |
2021-01-25 Tax Withholding | 2021-01-27 7:02 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 830 | $156.01 | 43,512 (Direct) | View |
2021-01-25 Tax Withholding | 2021-01-27 7:02 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 509 | $156.1 | 43,512 (Direct) | View |
2020-06-30 Other | 2020-07-01 8:06 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 238 | $89.03 | 41,353 (Direct) | View |
2020-02-15 Tax Withholding | 2020-02-18 5:07 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 881 | $97.23 | 69,243 (Direct) | View |
2020-02-13 Option Award | 2020-02-18 5:07 pm | N/A 2030-02-13 | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 21,055 | $0 | 69,243 (Direct) | View |
2019-12-20 Tax Withholding | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 1,131 | $105.87 | 49,069 (Direct) | View |
2019-12-20 Option Award | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary | 3,028 | $0 | 49,069 (Direct) | View |